ASTRO awards $35,500 in individual grants to 43 researchers presenting at the 2014 Annual Meeting

August 13, 2014

Fairfax, Va., August 13, 2014--The American Society for Radiation Oncology (ASTRO) has selected 43 recipients to receive a total of $35,500 for the 2014 Annual Meeting Abstract Awards. The awardees will be recognized at ASTRO's 56th Annual Meeting, September 14-17, 2014, at the Moscone Center in San Francisco.

"ASTRO's Annual Meeting showcases top radiation oncology research from around the world, and this year, a record-breaking 2,864 abstracts were submitted. This important research provides insight into significant advances in both technology and biology that Annual Meeting attendees can use to continue to move our field forward and to help improve cancer care for patients worldwide," said ASTRO President Bruce G. Haffty, MD, FASTRO. "Congratulations to the 43 researchers honored with these awards."

The Resident Clinical/Basic Science Research Abstract Award recognizes the top three resident authors of the leading abstracts in radiation and cancer biology, clinical practice and radiation physics (one award in each of these categories). Award winners will receive $1,500 and a trophy during the scientific session in which their abstract is presented. Recipients, who are ASTRO members, are either a current resident-in-training or out of training for up to one year. The 2014 Resident Clinical/Basic Science Research Abstract Award recipients are: The Resident Digital Poster Recognition Award honors the three highest rated abstracts selected for digital poster discussions by residents who are the lead author. Awards are presented for one abstract in each category: radiation and cancer biology, clinical practice and radiation physics. Awardees will be recognized with trophies during the Poster Viewing Reception on Monday, September 15 from 5:30 p.m. to 6:45 p.m. in Hall D. The 2014 Resident Digital Poster Recognition Award recipients are: The Resident Poster Viewing Recognition Award recognizes the highest rated, resident-submitted abstracts selected for paper poster presentations. The top three resident authors in each category (radiation and cancer biology, clinical practice and radiation physics) are awarded this recognition. Recipients receive the trophy award during the Poster Viewing Reception on Monday, September 15 from 5:30 p.m. to 6:45 p.m. in Hall D. The 2014 Resident Poster Viewing Recognition Award recipients are:

Clinical Practice: Radiation and Cancer Biology: Radiation Physics: The Basic Science Abstract Award recognizes up to 10 basic scientists (lead authors) of abstracts selected for presentation at the 2014 Annual Meeting, in the biology or physics categories, with a $1,000 grant and a certificate. Up to five awards are available in each category. Junior investigators must have completed an ACGME-accredited residency or PhD program no more than four years prior to the deadline, and senior investigators must be biologists or physicists four to 10 years post-PhD or board certification, whichever comes later. Recipients of the 2014 Basic Science Abstract Award are:

Radiation and Cancer Biology: Radiation Physics: The Annual Meeting Scientific Abstract/Travel Award recognizes outstanding abstracts submitted by early career scientists, biologists and physicists. Up to 15 awards of $1,000 each are given (five in each category) to help offset travel expenses to attend ASTRO's Annual Meeting. Awardees are the lead authors of high-scoring abstracts selected for presentation at the 2014 ASTRO Annual Meeting. The 2014 Annual Meeting Scientific Abstract Award recipients are:

Clinical Practice: Radiation and Cancer Biology: Radiation Physics: The International-U.S. Annual Meeting Scientific Abstract Award provides a $4,000 grant to a radiation oncologist from a developing country (as defined by the World Bank's criteria) to attend ASTRO's Annual Meeting and to spend one week at a comprehensive cancer center in the United States. The award fosters continuing medical education, assists in career development and aids in establishing relationships with ASTRO members who may serve as scientific mentors to the award winner. Recipients are the lead author of an abstract selected for presentation at the 2014 ASTRO Annual Meeting and have a letter of support from the chair/mentor of the U.S. institution that will host the awardee at their cancer center. The awardee must submit a written summary of their Annual Meeting participation and the experience garnered at the host cancer center. The award will be presented at the International Attendee Welcome Breakfast on Sunday, September 14 from 6:45 a.m. to 8:00 a.m. The recipient of the 2014 International - U.S. Annual Meeting Scientific Abstract Award is: The Annual Meeting Nurse Abstract Award honors the two highest rated abstracts with a nursing designation. Award candidates must be nurses who are the lead author or co-author of an abstract selected for presentation at the 2014 ASTRO Annual Meeting. Awardees will be recognized with a $1,000 grant and certificate at the Nurses' Luncheon on Saturday, September 13 from 11:30 a.m. to 12:45 p.m. The 2014 Annual Meeting Nurses' Abstract Award recipients are: ASTRO's 56th Annual Meeting, to be held at San Francisco's Moscone Center, September 14-17, 2014, is the nation's premier scientific meeting in radiation oncology. The 2014 Annual Meeting is expected to attract more than 11,000 attendees including oncologists from all disciplines, medical physicists, dosimetrists, radiation therapists, radiation oncology nurses and nurse practitioners, biologists, physician assistants, practice administrators, industry representatives and other health care professionals from around the world. Led by ASTRO President Bruce G. Haffty, MD, FASTRO, a radiation oncologist specializing in breast cancer, the theme of the 2014 Meeting is "Targeting Cancer: Technology and Biology," and the Presidential Symposium, "Local-regional Management of Breast Cancer: A Changing Paradigm," will feature Jay R. Harris, MD, FASTRO, and Thomas A. Buchholz, MD, FASTRO, to highlight recent practice-changing, landmark studies and current developments in the local-regional management of breast cancer. ASTRO's four-day scientific meeting includes presentation of up to four plenary papers, 360 oral presentations, 1,862 posters and 144 digital posters in more than 50 educational sessions and scientific panels for 20 disease-site tracks. Three keynote speakers will address a range of topics including oncologic imaging, biology and targeting in oncology, and human error and safety concerns: Hedvig Hricak, MD, PhD, Chair of the Department of Radiology and the Carroll and Milton Petrie Chair at Memorial Sloan Kettering Cancer Center; Frank McCormick, PhD, FRS, DSc (hon), Professor Emeritus and the David A. Wood Distinguished Professor of Tumor Biology and Cancer Research of the University of California at San Francisco Helen Diller Family Comprehensive Cancer Center; and Sidney Dekker, PhD, MA, MSc, Professor and Director of the Safety Science Innovation Lab at Griffith University, Brisbane, Australia.
For more information about ASTRO's 56th Annual Meeting, visit

For press registration and media policies for ASTRO's 56th Annual Meeting, visit


ASTRO is the premier radiation oncology society in the world, with more than 10,000 members who are physicians, nurses, biologists, physicists, radiation therapists, dosimetrists and other health care professionals that specialize in treating patients with radiation therapies. As the leading organization in radiation oncology, the Society is dedicated to improving patient care through professional education and training, support for clinical practice and health policy standards, advancement of science and research, and advocacy. ASTRO publishes two medical journals, International Journal of Radiation Oncology, Biology, Physics and Practical Radiation Oncology; developed and maintains an extensive patient website,; and created the Radiation Oncology Institute, a non-profit foundation to support research and education efforts around the world that enhance and confirm the critical role of radiation therapy in improving cancer treatment. To learn more about ASTRO, visit

American Society for Radiation Oncology

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to